Holen Sie sich die Stockscreener-App
1.68
1.18%
-0.02
MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten
Signal strength of MAIA Biotechnology Inc. stock in tech scanners2025 Pullback Review & Advanced Technical Analysis Signals - Newser
Will breakout in MAIA Biotechnology Inc. lead to full recoveryTrade Entry Report & Reliable Price Breakout Signals - newser.com
How hedge fund analytics apply to MAIA Biotechnology Inc. stock2025 Price Action Summary & Safe Entry Trade Reports - newser.com
How to integrate MAIA Biotechnology Inc. into portfolio analysis tools2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
What the charts say about MAIA Biotechnology Inc. todayEarnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser
Short interest data insights for MAIA Biotechnology Inc.Market Movers & Low Drawdown Momentum Ideas - Newser
MAIA Biotechnology Updates Business Presentation Online - TipRanks
MAIA Biotechnology Inc. stock volume spike explainedPortfolio Performance Report & Daily Profit Focused Stock Screening - Newser
What Fibonacci levels say about MAIA Biotechnology Inc. rebound2025 Market Trends & Technical Buy Zone Confirmation - Newser
What earnings revisions data tells us about MAIA Biotechnology Inc.Rate Cut & Daily Profit Maximizing Trade Tips - Newser
Published on: 2025-09-12 05:24:13 - Newser
Using economic indicators to assess MAIA Biotechnology Inc. potentialQuarterly Trade Report & Proven Capital Preservation Methods - Newser
Using portfolio simulators with MAIA Biotechnology Inc. included2025 Market WrapUp & Safe Entry Zone Tips - Newser
Is a relief rally coming for MAIA Biotechnology Inc. holdersJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
Will earnings trigger a reversal in MAIA Biotechnology Inc.Weekly Trend Summary & Community Driven Trade Alerts - Newser
What recovery options are there for MAIA Biotechnology Inc.Long Setup & Accurate Technical Buy Alerts - Newser
MAIA Biotechnology Reports Positive Phase 2 Trial Results - TipRanks
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer - The Manila Times
MAIA Biotechnology Highlights Positive Efficacy Data from - GlobeNewswire
124% Survival Improvement: MAIA Biotechnology's Lung Cancer Drug Doubles Standard Care Effectiveness - Stock Titan
Intraday pattern recognizer results for MAIA Biotechnology Inc.Market Activity Report & Expert-Curated Trade Recommendations - Newser
Heatmap analysis for MAIA Biotechnology Inc. and competitorsQuarterly Trade Summary & Precise Swing Trade Alerts - Newser
Published on: 2025-09-10 00:28:01 - Newser
Is MAIA Biotechnology Inc. reversing from oversold territoryJuly 2025 Reactions & High Conviction Investment Ideas - Newser
Comparing MAIA Biotechnology Inc. in custom built stock radarsJuly 2025 Levels & Accurate Intraday Trading Signals - Newser
Is MAIA Biotechnology Inc. stock a growth or value playWeekly Trade Recap & Stock Portfolio Risk Management - Newser
Strategies to average down on MAIA Biotechnology Inc.Weekly Trade Review & Verified Technical Signals - Newser
Does MAIA Biotechnology Inc. have pricing powerWatch List & Safe Capital Growth Plans - Lancaster City Council
Has MAIA Biotechnology Inc. formed a bullish divergenceInsider Selling & Smart Allocation Stock Tips - Newser
using portfolio simulators with maia biotechnology inc. includedAnalyst Downgrade & Safe Swing Trade Setup Alerts - Newser
Published on: 2025-09-09 02:06:15 - Newser
Order flow analysis tools used on MAIA Biotechnology Inc.July 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
Maia Biotechnology presents Phase 2 THIO-101 trial data at lung cancer conference - Investing.com Australia
0.93%
0.10%
Kapitalisierung:
|
Volumen (24h):